The recent advances of phenotypes in acute exacerbations of COPD

References

• VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• HanMKAgustiACalverleyPMChronic obstructive pulmonary disease phenotypes: the future of COPDAm J Respir Crit Care Med2010182559860420522794
   PubMed Web of Science ®Google Scholar
• HurstJRExacerbation phenotyping in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2011184662562621920921
   PubMed Web of Science ®Google Scholar
• Lopez-CamposJLAgustiAHeterogeneity of chronic obstructive pulmonary disease exacerbations: a two-axes classification proposalLancet Respir Med20153972973426165134
   PubMed Web of Science ®Google Scholar
• BurgeSWedzichaJACOPD exacerbations: definitions and classificationsEur Respir J Suppl20034146s53s12795331
   PubMedGoogle Scholar
• CelliBRBarnesPJExacerbations of chronic obstructive pulmonary diseaseEur Respir J20072961224123817540785
   PubMed Web of Science ®Google Scholar
• BegheBVerduriARocaMFabbriLMExacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPDEur Respir J201341499399523543648
   PubMed Web of Science ®Google Scholar
• DaiMYQiaoJPXuYHFeiGHRespiratory infectious phenotypes in acute exacerbation of COPD: an aid to length of stay and COPD Assessment TestInt J Chron Obstruct Pulmon Dis20151012257226326527871
   PubMed Web of Science ®Google Scholar
• WedzichaJADonaldsonGCExacerbations of chronic obstructive pulmonary diseaseRespir Care2003481212041213 discussion 1213–121514651761
   PubMedGoogle Scholar
• RohdeGBorgIWiethegeAInflammatory response in acute viral exacerbations of COPDInfection200836542743318795228
   PubMed Web of Science ®Google Scholar
• GarchaDSThurstonSJPatelARChanges in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPDThorax201267121075108022863758
   PubMed Web of Science ®Google Scholar
• DimopoulosGLerikouMTsiodrasSViral epidemiology of acute exacerbations of chronic obstructive pulmonary diseasePulm Pharmacol Ther2012251121821983132
   PubMed Web of Science ®Google Scholar
• WoodheadMBlasiFEwigSJoint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious DiseasesGuidelines for the management of adult lower respiratory tract infections – full versionClin Microbiol Infect201117Suppl 6E1E59
   PubMed Web of Science ®Google Scholar
• TanriverdiHOrnekTErboyFComparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPDWien Klin Wochenschr201512719–2075676325586444
   PubMed Web of Science ®Google Scholar
• O’DonnellDEAaronSBourbeauJCanadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 updateCan Respir J200714Suppl B5B32B
   PubMed Web of Science ®Google Scholar
• PauwelsRABuistASCalverleyPMJenkinsCRHurdSSGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summaryAm J Respir Crit Care Med200116351256127611316667
   PubMedGoogle Scholar
• KaradenizGPolatGSenolGBuyuksirinMC-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbationsInflammation201336494895323547018
   PubMed Web of Science ®Google Scholar
• PengCTianCZhangYYangXFengYFanHC-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary diseaseAm J Med Sci2013345319019423221507
   PubMed Web of Science ®Google Scholar
• StolzDChrist-CrainMMorgenthalerNGCopeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPDChest200713141058106717426210
   PubMed Web of Science ®Google Scholar
• CortiCFallyMFabricius-BjerreAPoint-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPDInt J Chron Obstruct Pulmon Dis2016111381138927382274
   PubMed Web of Science ®Google Scholar
• RammaertBVerdierNCavestriBNseirSProcalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary diseaseRespirology200914796997419659517
   PubMed Web of Science ®Google Scholar
• BozinovskiSHutchinsonAThompsonMSerum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008177326927818006888
   PubMed Web of Science ®Google Scholar
• Zien AlaabdenAMohammadYFahoumSThe role of serum surfactant protein D as a biomarker of exacerbation of chronic obstructive pulmonary diseaseQatar Med J2015201521826942111
   PubMedGoogle Scholar
• WangSChenYRenW益气活血法对慢性阻塞性肺疾病 急性加重患者血浆纤维蛋白原及 D – 二聚体的影响 [Effect of Qi benefiting blood activating method on plasma fibrinogen and D-dimer in patients with acute exacerbation of chronic obstructive pulmonary disease]Zhongguo Zhong Xi Yi Jie He Za Zhi2015355537540 Chinese26159014
   PubMedGoogle Scholar
• PapiABellettatoCMBraccioniFInfections and airway inflammation in chronic obstructive pulmonary disease severe exacerbationsAm J Respir Crit Care Med2006173101114112116484677
   PubMed Web of Science ®Google Scholar
• ClarkTWMedinaMJBathamSCurranMDParmarSNicholsonKGC-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPDEur Respir J2015451768625186260
   PubMed Web of Science ®Google Scholar
• TofanFRahimi-RadMHRasmiYRahimiradSHigh sensitive C-reactive protein for prediction of adverse outcome in acute exacerbation of chronic obstructive pulmonary diseasePneumologia201261316016223175870
   PubMedGoogle Scholar
• NseirSCavestriBDi PompeoCFactors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary diseaseRespiration200876325326018547944
   PubMed Web of Science ®Google Scholar
• DanielsJMSchoorlMSnijdersDProcalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPDChest201013851108111520576731
   PubMed Web of Science ®Google Scholar
• LinCPangQMeta-analysis and systematic review of procalcitonin-guided treatment in acute exacerbation of chronic obstructive pulmonary diseaseClin Respir J Epub2016622
   Web of Science ®Google Scholar
• ZhangLHuangJXuTLinY降钙素原指导抗生素治疗策略 在社区获得性下呼吸道感染巾应用的荟萃分析 [Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials]Zhonghua Jie He He Hu Xi Za Zhi2012354275282 Chinese22781200
   PubMedGoogle Scholar
• GroenewegenKHPostmaDSHopWCIncreased systemic inflammation is a risk factor for COPD exacerbationsChest2008133235035718198263
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTAMacCallumPKAcute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levelsThromb Haemost200084221021510959691
   PubMed Web of Science ®Google Scholar
• HoisethADNeukammAKarlssonBDOmlandTBrekkePHSoysethVElevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary diseaseThorax201166977578121653926
   PubMed Web of Science ®Google Scholar
• ValipourASchrederMWolztMCirculating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary diseaseClin Sci (Lond)2008115722523218307413
   PubMed Web of Science ®Google Scholar
• LiuHXuJY4一羟基壬烯醛在慢性阻塞性肺疾病严重程度评估 中的作用 [The role of 4-hydroxynonenal in assessment of chronic obstructive pulmonary disease severity]Zhonghua Jie He He Hu Xi Za Zhi20123510758761 Chinese23289993
   PubMedGoogle Scholar
• WuJFYangYHPangBS慢 性 阻 塞 性 肺 疾 病 急 性 加 重 患 者 血 浆 血 小 板 因 子 4及 13凝 血 球 蛋 白 水 平 的 变 化 及 其 意 义 [Platelet factor 4 and beta-thromboglobulin in blood plasma of patients with acute exacerbation of chronic obstructive pulmonary disease]Zhonghua Yi Xue Za Zhi2013931813781382 Chinese24025501
   PubMedGoogle Scholar
• KaradagFKarulABCildagOYilmazMOzcanHBiomarkers of systemic inflammation in stable and exacerbation phases of COPDLung2008186640340918807087
   PubMed Web of Science ®Google Scholar
• DummerJFEptonMJCowanJOPredicting corticosteroid response in chronic obstructive pulmonary disease using exhaled nitric oxideAm J Respir Crit Care Med2009180984685219661244
   PubMed Web of Science ®Google Scholar
• KunisakiKMRiceKLJanoffENRectorTSNiewoehnerDEExhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective studyTher Adv Respir Dis200822556419124359
   PubMedGoogle Scholar
• AminKJansonCBystromJRole of eosinophil granulocytes in allergic airway inflammation endotypesScand J Immunol2016842758527167590
   PubMed Web of Science ®Google Scholar
• DonohueJFHerjeNCraterGRickardKCharacterization of airway inflammation in patients with COPD using fractional exhaled nitric oxide levels: a pilot studyInt J Chron Obstruct Pulmon Dis2014974575125053884
   PubMed Web of Science ®Google Scholar
• AntusBBartaIHorvathICsiszerERelationship between exhaled nitric oxide and treatment response in COPD patients with exacerbationsRespirology201015347247720210889
   PubMed Web of Science ®Google Scholar
• GaoPZhangJHeXHaoYWangKGibsonPGSputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary diseasePLoS One201385e5767823741289
   PubMed Web of Science ®Google Scholar
• van VeenIHTen BrinkeAGauwSASterkPJRabeKFBelEHConsistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up studyJ Allergy Clin Immunol20091243615617617.e1617.e219733302
   PubMed Web of Science ®Google Scholar
• BafadhelMMcKennaSTerrySAcute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkersAm J Respir Crit Care Med2011184666267121680942
   PubMed Web of Science ®Google Scholar
• LacomaAPratCAndreoFValue of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2011615716921468168
   PubMed Web of Science ®Google Scholar
• AnthonisenNRManfredaJWarrenCPHershfieldESHardingGKNelsonNAAntibiotic therapy in exacerbations of chronic obstructive pulmonary diseaseAnn Intern Med198710621962043492164
   PubMed Web of Science ®Google Scholar
• StolzDChrist-CrainMBingisserRAntibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapyChest2007131191917218551
   PubMed Web of Science ®Google Scholar
• StockleyRAO’BrienCPyeAHillSLRelationship of sputum color to nature and outpatient management of acute exacerbations of COPDChest200011761638164510858396
   PubMed Web of Science ®Google Scholar
• AaronSDDonaldsonGCWhitmoreGAHurstJRRamsayTWedzichaJATime course and pattern of COPD exacerbation onsetThorax201267323824322008189
   PubMed Web of Science ®Google Scholar
• WedzichaJASeemungalTACOPD exacerbations: defining their cause and preventionLancet2007370958978679617765528
   PubMed Web of Science ®Google Scholar
• MasoompourSMMohammadiAMahdaviazadHAdherence to the Global initiative for chronic obstructive lung disease guidelines for management of COPD: a hospital-base studyClin Respir J201610329830225308344
   PubMed Web of Science ®Google Scholar
• AlmagroPCabreraFJDiezJComorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en servicios de medicina interna (ESMI) studyChest201214251126113323303399
   PubMed Web of Science ®Google Scholar
• MiravitllesMCalleMSoler-CatalunaJJClinical phenotypes of COPD: identification, definition and implications for guidelinesArch Bronconeumol2012483869822196477
   PubMed Web of Science ®Google Scholar
• HuertaACrisafulliEMenendezRPneumonic and nonpneumonic exacerbations of COPD: inflammatory response and clinical characteristicsChest201314441134114223828375
   PubMed Web of Science ®Google Scholar
• RocaMRocaICMihaescuTLung cancer – a comorbidity in chronic obstructive pulmonary diseaseRev Med Chir Soc Med Nat Iasi201211641055106223700888
   PubMedGoogle Scholar
• BarrechegurenMEsquinasCMiravitllesMThe asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challengesCurr Opin Pulm Med2015211747925405671
   PubMed Web of Science ®Google Scholar
• AdubatoSMenackerMACOs and the future of medicine: an interview with Morey Menacker, DOMD Advis20147246
   Google Scholar
• ZekiAASchivoMChanAAlbertsonTELouieSThe asthma-COPD overlap syndrome: a common clinical problem in the elderlyJ Allergy (Cairo)2011201186192622121384
   PubMedGoogle Scholar
• Martinez-GarciaMAde la Rosa CarrilloDSoler-CatalunaJJPrognostic value of bronchiectasis in patients with moderate-to-severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187882383123392438
   PubMed Web of Science ®Google Scholar
• ChenYHSunYCBronchiectasis as a comorbidity of chronic obstructive pulmonary disease: implications and future researchChin Med J (Engl)2016129172017201927569224
   PubMed Web of Science ®Google Scholar
• MacNeeWSystemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary diseaseAnn Med201345329130023110517
   PubMed Web of Science ®Google Scholar
• LarattaCRvan EedenSAcute exacerbation of chronic obstructive pulmonary disease: cardiovascular linksBiomed Res Int2014201452878924724085
   PubMed Web of Science ®Google Scholar
• FabbriLMLuppiFBegheBRabeKFComplex chronic comorbidities of COPDEur Respir J200831120421218166598
   PubMed Web of Science ®Google Scholar
• SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
   PubMed Web of Science ®Google Scholar
• DoddJWCharltonRAvan den BroekMDJonesPWCognitive dysfunction in patients hospitalized with acute exacerbation of COPDChest2013144111912723349026
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• ArosteguiIEstebanCGarcia-GutierrezSSubtypes of patients experiencing exacerbations of COPD and associations with outcomesPLoS One201496e9858024892936
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• TashkinDPFrequent exacerbations of chronic obstructive pulmonary disease – a distinct phenotype?N Engl J Med2010363121183118420843256
   PubMed Web of Science ®Google Scholar
• WedzichaJABrillSEAllinsonJPDonaldsonGCMechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary diseaseBMC Med20131118123945277
   PubMed Web of Science ®Google Scholar
• DonaldsonGCSeemungalTAPatelISAirway and systemic inflammation and decline in lung function in patients with COPDChest200512841995200416236847
   PubMed Web of Science ®Google Scholar
• BhowmikASeemungalTASapsfordRJWedzichaJARelation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbationsThorax200055211412010639527
   PubMed Web of Science ®Google Scholar
• SeemungalTAWilkinsonTMHurstJRPereraWRSapsfordRJWedzichaJALong-term erythromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbationsAm J Respir Crit Care Med2008178111139114718723437
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJFarreroEFelezMARisk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax200358210010512554887
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJRodriguez-RoisinRFrequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?COPD20107427628420673037
   PubMedGoogle Scholar
• MiravitllesMSoler-CatalunaJJCalleMA new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)Prim Care Respir J201322111712123443227
   PubMedGoogle Scholar
• AlbertRKConnettJBaileyWCAzithromycin for prevention of exacerbations of COPDN Engl J Med2011365868969821864166
   PubMed Web of Science ®Google Scholar
• PoolePJBlackPNMucolytic agents for chronic bronchitis or chronic obstructive pulmonary diseaseCochrane Database Syst Rev20063CD001287
   PubMedGoogle Scholar
• FergusonGTAnzuetoAFeiREmmettAKnobilKKalbergCEffect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbationsRespir Med200810281099110818614347
   PubMed Web of Science ®Google Scholar
• HoogendoornMFeenstraTLHoogenveenRTAlMMolkenMRAssociation between lung function and exacerbation frequency in patients with COPDInt J Chron Obstruct Pulmon Dis2010543544421191438
   PubMedGoogle Scholar
• CarolanBJSutherlandERClinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advancesJ Allergy Clin Immunol20131313627634 quiz 63523360757
   PubMed Web of Science ®Google Scholar
• LinCLSiuLKLinJCMannose-binding lectin gene polymorphism contributes to recurrence of infective exacerbation in patients with COPDChest20111391435120688922
   PubMed Web of Science ®Google Scholar
• ForemanMGDeMeoDLHershCPPolymorphic variation in surfactant protein B is associated with COPD exacerbationsEur Respir J200832493894418550614
   PubMed Web of Science ®Google Scholar
• WellsJMWashkoGRHanMKPulmonary arterial enlargement and acute exacerbations of COPDN Engl J Med20123671091392122938715
   PubMed Web of Science ®Google Scholar
• Sarinc UlasliSBozbasSSOzenZEOzyurekBAUlubayGEffect of thyroid function on COPD exacerbation frequency: a preliminary studyMultidiscip Respir Med2013816424079533
   PubMed Web of Science ®Google Scholar
• HuertaADonaldsonGCSinghRUpper respiratory symptoms worsen over time and relate to clinical phenotype in chronic obstructive pulmonary diseaseAnn Am Thorac Soc2015127997100425938279
   PubMed Web of Science ®Google Scholar
• MorrowJDQiuWChhabraDIdentifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methodsBMC Med Genomics20158125582225
   PubMed Web of Science ®Google Scholar
• OhYMSheenSSParkJHEmphysematous phenotype is an independent predictor for frequent exacerbation of COPDInt J Tuberc Lung Dis201418121407141425517804
   PubMed Web of Science ®Google Scholar
• SinghDFoxSMTal-SingerRBatesSRileyJHCelliBAltered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohortPLoS One201499e10738125265030
   PubMed Web of Science ®Google Scholar